Pharmafile Logo
Pharmafocus logo
Advanced Search

AI

Showing 15 posts of 83 posts found.

Anavex Life Sciences and Partex NV Group announce AI-based strategic partnership to enhance patient experience

June 28, 2023
Research and Development AI, Anavex Life Sciences, Partex NV Group, Pharmacy, patient experience

US-based clinical-stage biopharmaceutical company Anavex Life Sciences and German digital pharma platform Partex NV Group have announced a strategic partnership …

News

Scientists use AI to find new antibiotic to fight superbug

May 26, 2023
Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …

News
pers

Personalised medicine in oncology: Where are we now?

June 30, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …

Feature
laboratory-testing-az

Exscientia to collaborate with EQRx on drug development

June 25, 2021
Medical Communications AI, Exscientia, clinical drug development

Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …

News

Novartis announce digital collaboration with HPE

June 24, 2021
AI, HPE, Novartis

Swiss pharma company, Novartis, has announced a collaboration with Hewlett Packard Enterprise (HPE), to accelerate its use of data and …

News

UK AI firm wins share of £140 million funding for lung cancer detection tech

June 18, 2021
Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology

Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …

News

Exscientia buys Austrian cancer cell screening company for €50 million

June 17, 2021
AI, EU, deal, marketing, sales

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 million. The multimillion deal, paid …

News
1c64f360-c5ef-43b6-bcef-13cede36f571

Lucida Medical gains CE marking for AI prostate cancer tech

June 1, 2021
Manufacturing and Production AI, MRI, NHS, prostate cancer

Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …

News
andrei_r_-_shutterstock_1935537274_720

Ori Biotech and Vineti to collaborate on CGT manufacturing

May 26, 2021
Research and Development AI, CGTs

Ori Biotech and Vineti have announced a strategic partnership to produce pre-integrated solutions to fast-track and streamline the manufacture and …

News

Exscientia and BMS announce $1.2 billion collaboration

May 19, 2021
Research and Development AI

Artificial intelligence (AI) pharmatech company, Exscientia, has announced a collaboration with Bristol Myers Squibb to accelerate the discovery of small …

News

Oxford University to collaborate with Oracle on COVID variant research

May 17, 2021
Sales and Marketing AI, COVID-19, Oxford, variants

In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …

News

PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes

May 17, 2021
Sales and Marketing AI, drug discovery

PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …

News
biogen_austria_238

Biogen to collaborate with Envisagenics on RNA splicing research

May 14, 2021
Medical Communications AI

Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …

News

Exscientia launch trial of third AI-designed molecule

May 13, 2021
AI, Altzeimer's, Exscientia

Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …

News

Facio Therapies announces AI collaboration for FSHD drug design

May 11, 2021
Manufacturing and Production AI, drug discovery

Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …

News
The Gateway to Local Adoption Series

Latest content

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026

Axplora consolidates liver disease API manufacturing in India

June 23, 2026

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026